Related coverage linked through entity extraction aliases.
Jul 01, 2026
FDA approved Medtronic's Hugo for urologic procedures; a new robotic and AR system showed high precision in jaw surgery; East and Central Africa saw its first robotic-assisted knee replacements.
May 26, 2026
Yale researchers built genomic AI models for personalized medicine. The University of Liverpool and BPGbio will expand AI drug discovery via the NAi platform.
Aug 07, 2026
China has become the dominant source of external drug innovation, with pharma licensing deals reaching $135.7 billion in 2025 and China developing 30% of the world's new innovative drugs. Meanwhile, India is expanding AI use in drug discovery and strengthening its CRDMO and IP infrastructure, though investment gaps persist.
Jul 03, 2026
China's 12th national Volume-Based Procurement round places RMB 60 billion across 65 drug varieties, accelerating generics and biosimilars substitution. Separately, Genialis launched BioBridge to help translate Chinese oncology trial results into Western development programs, as Chinese out-licensing hit $137.7 billion in 2025.
Jun 06, 2026
Penn State College of Medicine held its 2026 Research and Innovation Awards luncheon on April 21, and Stanford Medicine's Department of Epidemiology and Population Health honored faculty and students with student-selected awards for community and teaching.
Jul 02, 2026
New strategies to overcome cancer drug resistance target persister cells, disable DNA repair with UNI418, and use tri-click ligands to damage DNA. The findings may help re-sensitize resistant tumors to therapy.
Jun 02, 2026
AI-driven studies are advancing cancer drug discovery across multiple tumor types, including a pan-cancer proposal of AMG-900, a novel gp130 inhibitor for colorectal cancer, and the Kinic Index for hepatocellular carcinoma. Machine learning is also being integrated into computational platforms like Isomorphic Labs' IsoDDE to model molecular interactions.
Aug 02, 2026
New research advances sustainable biotechnology: recreating poisonous plant compounds for medicine, a two-step fermentation that removes up to 99% of off-putting smells, and hybrid plants that cut carbon footprints by 62%.
Aug 08, 2026
Recent studies have uncovered new cancer therapeutic targets and strategies, including self-assembling antibody-drug conjugates, a dual-action metabolic drug, and a BRAF protein structure. Research also advanced on dendritic cell vaccines, the origins of a rare childhood leukemia, and cancer cachexia treatment.
May 16, 2026
Three-time cervical cancer survivor Samantha Gonzales-Russell urges patients to trust their instincts, seek second opinions and advocate for themselves. She emphasizes that persistent symptoms like abnormal bleeding or pain should never be dismissed, and that mental health support should be part of cancer care from the start.
Jul 01, 2026
A study published in Menopause found that initiating hormone therapy after age 65 is associated with increased risks for any cancer and cerebrovascular accidents. The analysis of 83,147 women also showed elevated hazards for cancer and vascular events among those who initiated HT at ages 50 to 65.
Jul 08, 2026
Researchers developed a cell-free cartilage scaffold that guides bone regeneration without strong immune reactions. The off-the-shelf graft, tested in animals, could replace costly patient-specific grafts. Human trials are being prepared.
Jul 05, 2026
XBiotech Inc. (NASDAQ: XBIT) is a clinical-stage biopharmaceutical company specializing in True Human monoclonal antibodies. Pipeline candidates include Natrunix and Hutrukin. The company is held by small-cap value ETFs.
May 22, 2026
Advanced Biomed and Chi-Mei Medical Center launched a 120-case feasibility study of the A+PerfusC platform, comparing drug sensitivity results from liquid biopsy with patient outcomes. Interim data expected in mid-2026.
Aug 01, 2026
Research shows depression can raise cancer mortality by 23–83%, and the emotional toll of a diagnosis may be compounded by seasonal mood changes. Experts urge integrating mental health support into cancer care to improve outcomes.
Aug 01, 2026
A digital mental health program significantly reduced anxiety in breast cancer survivors, with additional coaching helping depression, while a broader review finds eHealth tools improve psychological support in cancer care.
Jul 30, 2026
When a parent is diagnosed with cancer, Mount Sinai’s Child Life and Creative Arts Therapy team offers age-appropriate, therapeutic support to help children cope. Services include education, play activities, and art therapy, fostering communication and resilience.
Jul 27, 2026
AstraZeneca Q2 core EPS of $2.63 beat consensus, driven by 15% oncology and 8% rare disease growth. The company maintained its 2030 $80 billion revenue target and has more than 20 Phase III readouts expected over the next 18 months.
Jul 27, 2026
InnoCare's TYK2 inhibitor fadeucravacitinib met primary and secondary endpoints in a Phase 3 psoriasis trial, with a favorable safety profile. InnoCare plans to seek regulatory approval.
Jul 24, 2026
A sustained telehealth program combining counseling and nicotine replacement therapy boosted 6-month smoking abstinence to 28.4% vs. 14.7% with quitline referral, a national trial found. The intervention was well-engaged and satisfied patients.
